GB Sciences Inc.
Rank 129
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
$0.1540
USD
0.03%
Market cap
$37,249,312
Total volume
$76,965
Shares outstanding
241,878,652
Reserved shares
158,121,348
Rank 129
About
GB Sciences is a company built on the pursuit of cannabis-based medications. By using a proprietary tissue propagation technique, they do not need to cultivate cannabis from a seed. Their pharm-grade facility in Las Vegas, Nevada is responsible for cultivation, curing and extraction. Research partners include several US-based universities.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
GBLX |
$76,965
|
100% |
$0.1540
|
Chart